Related Experiment Video

Updated: Sep 26, 2026

Identification of Functionally-Relevant Lentivirus Integration Sites in an Insertional Mutagenesis Cell Library
07:28

Identification of Functionally-Relevant Lentivirus Integration Sites in an Insertional Mutagenesis Cell Library

Published on: January 10, 2025

Retroviral insertional mutagenesis: tagging cancer pathways

Harald Mikkers1, Anton Berns

  • 1Division of Molecular Genetics and Centre of Biomedical Genetics, Netherlands Cancer Institute 1066 CX, Amsterdam, The Netherlands.

Advances in Cancer Research
|April 1, 2003
PubMed

Insights

Moloney murine leukemia virus (M-MuLV) causes tumors by inserting its DNA into the host genome, activating oncogenes and disabling tumor suppressors. Proviral tagging efficiently identifies cooperating cancer signaling pathways.

Area of Science:

  • Oncology
  • Virology
  • Genetics

Background:

  • Slow transforming retroviruses, like Moloney murine leukemia virus (M-MuLV), induce tumors after a significant latency period.
  • Tumorigenesis is driven by proviral insertions that activate proto-oncogenes or inactivate tumor suppressor genes.
  • Proviral insertions in tumor cells represent cooperating oncogenic events in multistep cancer development.

Purpose of the Study:

  • To leverage proviral tagging as an efficient method for identifying cooperating signaling pathways in cancer.
  • To utilize advances in genomics and genetic engineering for enhanced discovery in cancer research.

Main Methods:

  • Proviral tagging using Moloney murine leukemia virus (M-MuLV).
  • High-throughput isolation of proviral flanking sequences.
  • Utilizing genetically modified animals and the complete mouse genome sequence.

Main Results:

  • Proviral insertions mark genes contributing to tumorigenesis.
  • Identification of numerous proto-oncogenes in retrovirally induced tumors.
  • Demonstration of cooperating oncogenic events in tumor development.

Conclusions:

  • Proviral tagging is a powerful approach to identify cooperating signaling pathways in cancer.
  • Advances in genomic technologies have revolutionized the efficiency of proviral tagging.
  • Understanding cooperating oncogenic events is crucial for deciphering complex cancer biology.

More Related Videos

Identification and Characterization of Metastatic Factors by Gene Transfer into the Novel RIP-Tag; RIP-tva Murine Model09:03

Identification and Characterization of Metastatic Factors by Gene Transfer into the Novel RIP-Tag; RIP-tva Murine Model

Published on: October 16, 2017

Retroviral Scanning: Mapping MLV Integration Sites to Define Cell-specific Regulatory Regions10:10

Retroviral Scanning: Mapping MLV Integration Sites to Define Cell-specific Regulatory Regions

Published on: May 28, 2017

Related Concept Videos

Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...